← Leaderboards
Leigh Beglinger
University Of Iowa
$800,626
Attributed
$800,626
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $162.2K · FY2006–11$200K$150K$100K$50K$0
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$800,626 · 5
By mechanism
K23$787,805 · 1
M01$12,821 · 4
Top collaborators
No co-investigators on record.
Most similar at University Of Iowa
Same institution · by research overlap
- Henry L Paulson$29,880,294
- Daniel T Tranel$13,034,491
- Beverly L Davidson$40,254,264
- Mark Anthony Yorek$7,990,158
- Matthew A. Howard$16,264,246
Others in their field
Top investigators on “Motor”
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Jane S Paulsen · University Of Wisconsin-Madison$53,147,245
- Jerrold L Vitek · University Of Minnesota$52,399,244
- Merit E Cudkowicz · Massachusetts General Hospital$49,510,334
- Michael M Johns · Emory University$49,234,033
- David A Bennett · Rush University Medical Center$37,162,250
Research focus
MotorFundingPlacebosResearch PersonnelResourcesHuntington DiseaseAttentionExecutive FunctionPerformanceAdultCognitiveSymptomsFunctional StatusSelective Serotonin Reuptake InhibitorEffectivenessCognitive FunctionPatient Self-ReportProductivityGenesClinical TrialsHealth Related Quality Of LifeCitalopramEthicsCaregivers
Grant awards (9)
Cognition in Clinical Trials for Huntington's Disease$160,509
K23 · FY2011 · NS · contact PI
Cognition in Clinical Trials for Huntington's Disease$161,599
K23 · FY2010 · NS · contact PI
Cognition in Clinical Trials for Huntington's Disease$158,527
K23 · FY2009 · NS · contact PI
Cognition in Clinical Trials for Huntington's Disease$155,145
K23 · FY2008 · NS · contact PI
Cognition in Clinical Trials for Huntington's Disease$152,025
K23 · FY2007 · NS · contact PI
ETHYL-EPA (MIRAXION) IN SUBJECTS WITH MILD TO MODERATE HUNTINGTON'S DISEASE (HD)$4,476
M01 · FY2007 · RR · contact PI
ATOMOXETINE FOR ATTENTION DEFICITS IN ADULTS WITH MILD HD$4,069
M01 · FY2007 · RR · contact PI
A RANDOMIZED, PLACEBO-CONTROLLED PILOT STUDY IN HUNTINGTON'S DISEASE (CIT-HD)$1,629
M01 · FY2007 · RR · contact PI
ETHYL-EPA (MIRAXION) IN SUBJECTS WITH MILD TO MODERATE HUNTINGTON'S DISEASE (HD)$2,647
M01 · FY2006 · RR · contact PI